Relevant laboratory parameters in patients at hospital admission between July 2020 and October 2021 due to covid-19 at the Tesãi Foundation Hospital

Dennise María Villanueva González; Eliana Romina Meza Miranda

doi:10.53732/rccsalud/04.02.2022.27

Autores/as

Dennise María Villanueva González Universidad Nacional de Asunción. Centro Multidisciplinario de Investigaciones Tecnológicas. San Lorenzo, Paraguay https://orcid.org/0000-0001-6390-3379
Eliana Romina Meza Miranda Centro Multidisciplinario de Investigaciones de la Universidad de Asunción https://orcid.org/0000-0001-9791-8835

DOI:

https://doi.org/10.53732/rccsalud/04.02.2022.27

Palabras clave:

biomarcadores, valores críticos de laboratorio, COVID-19

Resumen

Introducción: En la lucha contra el COVID-19 es urgente la identificación de predictores de laboratorio en la progresión de formas graves y fatales. Objetivo: Describir las alteraciones de los parámetros de laboratorio de pacientes con COVID 19 ingresados al Hospital Fundación Tesãi de Ciudad del Este-Paraguay en el período de julio de 2020 a octubre de 2021. Métodos: Estudio retrospectivo, utilizando los registros de 103 pacientes ingresados al hospital por diagnóstico de COVID 19. Se recolectaron datos demográficos, clínicos y de laboratorio al ingreso hospitalario. Resultados: El 53,4% de los pacientes era del sexo masculino, edad media de 62,3±15,4 años y el 43,6% ingresó por neumonía. El 54,3% presentaba linfopenia, el 26% trombocitopenia y el 27% anemia. En el perfil hepático y renal, el 37,9% tenían niveles elevados de urea, el 56,3% niveles elevados de GOT, 26% y 61% niveles elevados de GPT y GGT, respectivamente. En cuanto a los biomarcadores, el 80 % tenía niveles elevados de LDH, el 34 % niveles elevados de dímero D, el 100 % proteína C reactiva elevada, el 43,7 % procalcitonina elevada y el 89,3 % ferritina elevada. Se encontraron diferencias significativas (p<0,05) según el sexo en los parámetros de hemoglobina, hematocrito, creatinina y el índice LMR. Conclusión. Los pacientes presentaron diversas alteraciones en casi todos los parámetros evaluados, resultados que ofrecen un panorama general del estado de salud con el que ingresa el paciente con COVID 19 al hospital.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

2. De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–34. https://doi.org/10.1038/nrmicro.2016.81 DOI: https://doi.org/10.1038/nrmicro.2016.81

3. Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Research 2013; 100(1): 286–95. https://doi.org/10.1016/j.antiviral.2013.08.015 DOI: https://doi.org/10.1016/j.antiviral.2013.08.015

4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2019;382:727-33. https://doi.org/10.1056/nejmoa2001017 DOI: https://doi.org/10.1056/NEJMoa2001017

5. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report—81. https://apps.who.int/iris/handle/10665/331779

6. BMJ Best Practice. Coronavirus Disease 2019 (COVID-19). https://bestpractice.bmj.com/topics/en-gb/3000201

7. Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol 2020;30(3):313–24. https://doi.org/10.4014/jmb.2003.03011 DOI: https://doi.org/10.4014/jmb.2003.03011

8. Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19- RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J Clin Microbiol 2020; 58(5):e00310-20. https://pubmed.ncbi.nlm.nih.gov/32132196/ DOI: https://doi.org/10.1128/JCM.00310-20

9. Ferrari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem Lab Med. 2020;58(7):1095-1099. https://doi.org/10.1515/cclm-2020-0398 DOI: https://doi.org/10.1515/cclm-2020-0398

10. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-847. https://pubmed.ncbi.nlm.nih.gov/32282949/ DOI: https://doi.org/10.1002/ajh.25829

11. Zhang JJ, Cao YY, Dong X, Wang BC, Liao MY, Lin J, et al. Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2. Allergy. 2020;75(7):1809-1812. https://pubmed.ncbi.nlm.nih.gov/32281110/ DOI: https://doi.org/10.1111/all.14316

12. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. https://doi.org/10.1001/jamainternmed.2020.0994 DOI: https://doi.org/10.1001/jamainternmed.2020.0994

13. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. https://doi.org/10.1016/s2213-2600(20)30079-5 DOI: https://doi.org/10.1016/S2213-2600(20)30079-5

14. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-118. https://doi.org/10.1016/j.jaci.2020.04.006 DOI: https://doi.org/10.1016/j.jaci.2020.04.006

15. Wang K, Zhang Z, Yu M, Tao Y, Xie M. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intensive Care Med. 2020;46(7):1472-1474. https://doi.org/10.1007/s00134-020-06047-w DOI: https://doi.org/10.1007/s00134-020-06047-w

16. Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020;10(6):514-520. https://doi.org/10.1080/20009666.2020.1816276

17. Abadi MSS, Taheri E, Raesi A, Arjmand MH, Kheirii S, Shahinfard N, et al. Procalcitonin as a prognostic factor in patients with COVID-19 in southwestern Iran. Infect Disord Drug Targets. 2022; 22(3):e070122200097. https://doi.org/10.2174/1871526522666220107141109 DOI: https://doi.org/10.2174/1871526522666220107141109

18. Cao P, Wu Y, Wu S, Wu T, Zhang Q, Zhang R, et al. Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia. Biomarkers. 202;26(3):207-212. https://doi.org/10.1080/1354750x.2020.1861098 DOI: https://doi.org/10.1080/1354750X.2020.1861098

19. Qeadan F, Tingey B, Gu LY, Packard AH, Erdei E, Saeed AI. Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19. Viruses. 2021;13(3):419. https://doi.org/10.3390/v13030419 DOI: https://doi.org/10.3390/v13030419

20. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–6 https://pubmed.ncbi.nlm.nih.gov/32181911/ DOI: https://doi.org/10.1002/jmv.25770

21. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131-1134. https://doi.org/10.1515/cclm-2020-0198 DOI: https://doi.org/10.1515/cclm-2020-0198

22. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4 https://doi.org/10.1001/jama.2013.281053 DOI: https://doi.org/10.1001/jama.2013.281053

23. Álvarez-Arroyo Laura, Carrera-Hueso Francisco J., El-Qutob David, Robustillo-Villarino Montserrat, Girona-Sanz Ana M., Pin-Godos María T. et al. Estudio descriptivo de una cohorte de pacientes con COVID-19 hospitalizados en España. Gac Méd Méx. 2021;157(1):80-87. https://doi.org/10.24875/gmm.20000605 DOI: https://doi.org/10.24875/GMM.20000605

24. Montiel D, Torres E, Acosta A, Sobarzo P, Pérez H, Ávalos D, Ramos Y. Características clínicas, laboratoriales y predictores de mortalidad de pacientes con COVID-19 internados en el Hospital Nacional. Rev Cient Cienc Salud. 2021;3(1):26-37. https://doi.org/10.53732/rccsalud/03.01.2021.26 DOI: https://doi.org/10.53732/rccsalud/03.01.2021.26

25. Vera N, Saavedra-Hernández D, Hidalgo-Mesa C, Aguila-López M, Abreu-Gutiérrez G, Herrera-González V, et al. Parámetros de laboratorio clínico en pacientes con la COVID-19. Rev Cub Med Mil. 2021;50(2): e02101171. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572021000200018

26. Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste L, et al. Critical COVID-19 France Investigators. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study. Arch Cardiovasc Dis. 2021;114(5):352-363. https://doi.org/10.1016/j.acvd.2021.01.003 DOI: https://doi.org/10.1016/j.acvd.2021.01.003

27. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. 10.1056/NEJMoa2002032 DOI: https://doi.org/10.1056/NEJMoa2002032

28. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20):2052-2059. https://doi.org/10.1001/jama.2020.6775 DOI: https://doi.org/10.1001/jama.2020.6775

29. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterization protocol: prospective observational cohort study. BMJ. 2020; 369:m1985. https://doi.org/10.1136/bmj.m1985 DOI: https://doi.org/10.1136/bmj.m1985

30. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1,591 patients infected with SARS CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. https://doi.org/10.1001/jama.2020.5394 DOI: https://doi.org/10.1001/jama.2020.4031

31. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-5. https://doi.org/10.1016/j.ijid.2020.03.017 DOI: https://doi.org/10.1016/j.ijid.2020.03.017

32. Sarhan AR, Hussein TA, Flaih MH, Hussein KR. A Biochemical Analysis of Patients with COVID-19 Infection. Biochem Res Int. 2021; 1383830. https://doi.org/10.1155/2021/1383830 DOI: https://doi.org/10.1155/2021/1383830

33. Yuan X, Huang W, Ye B, Chen C, Huang R, Wu F, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553-559. https://doi.org/10.1007/s12185-020-02930-w DOI: https://doi.org/10.1007/s12185-020-02930-w

34. Zhu Y, Cao X, Tao G, Xie W, Hu Z, Xu D. The lymph index: a potential hematological parameter for viral infection. Int J Infect Dis. 2013;17(7): e490–e493493. https://doi.org/10.1016/j.ijid.2012.12.002 DOI: https://doi.org/10.1016/j.ijid.2012.12.002

35. Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Le infezioni in medicina. 2020;28(2):174–84. https://pubmed.ncbi.nlm.nih.gov/32275259/

36. Al-Tawfq JA, Hinedi K, Abbasi S, Babiker M, Sunji A, Eltigani M. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int J Lab Hematol. 2017;39(3):272–8. https://pubmed.ncbi.nlm.nih.gov/28444873/ DOI: https://doi.org/10.1111/ijlh.12620

37. Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, et al. Middle East respiratory syndrome coronavirus efciently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213(6):904–14. https://doi.org/10.1093/infdis/jiv380 DOI: https://doi.org/10.1093/infdis/jiv380

38. Gonze A, Hannesse C, Coppens N, Vellemans H, Maury G. SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura. J Med Cases. 2020;11(6):166-168. https://doi.org/10.14740/jmc3481 DOI: https://doi.org/10.14740/jmc3481

39. Chen W, Li Z, Yang B, Wang P, Zhou Q, Zhang Z, et al. Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19). Br J Haematol. 2020;190(2):179-184. https://pubmed.ncbi.nlm.nih.gov/32453877/ DOI: https://doi.org/10.1111/bjh.16885

40. Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. 2020;92(11):2277-2282. https://pubmed.ncbi.nlm.nih.gov/32619062/ DOI: https://doi.org/10.1002/jmv.26251

41. Chen C, Zhou W, Fan W, Ning X, Yang S, Lei Z, Zheng C. Association of anemia and COVID-19 in hospitalized patients. Future Virol. 2021:10.2217/fvl-2021-0044. 10.2217/fvl-2021-0044 DOI: https://doi.org/10.21203/rs.3.rs-124998/v1

42. Huang D, Yang H, Yu H, Wang T, Chen Z, Zongan L, Rong Y. Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19). Int J Gen Med. 2021;14:4711–21. https://doi.org/10.2147/ijgm.s326204 DOI: https://doi.org/10.2147/IJGM.S326204

43. Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, et al. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int. 2020;14(5):711–22. https://doi.org/10.1007/s12072-020-10071-9 DOI: https://doi.org/10.1007/s12072-020-10071-9

44. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028. https://doi.org/10.1515/cclm-2020-0369 DOI: https://doi.org/10.1515/cclm-2020-0369

45. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389–99. https://doi.org/10.1080/10408363.2020.1770685 DOI: https://doi.org/10.1080/10408363.2020.1770685

46. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856-862. https://pubmed.ncbi.nlm.nih.gov/32281668/ DOI: https://doi.org/10.1002/jmv.25871

47. Tang N, Li D, Wang X. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. https://pubmed.ncbi.nlm.nih.gov/32073213/ DOI: https://doi.org/10.1111/jth.14768

48. Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020;120(5):876-878. https://doi.org/10.1055/s-0040-1709650 DOI: https://doi.org/10.1055/s-0040-1709650

49. Martins EC, Silveira LDF, Viegas K, Beck AD, Fioravantti Júnior G, Cremonese RV, et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Rev Bras Ter Intensiva. 2019;31(1):64-70. https://doi.org/10.5935/0103-507x.20190010 DOI: https://doi.org/10.5935/0103-507X.20190010

50. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine (Baltimore). 2018;97(26): e11138. https://journals.lww.com/md-journal/Fulltext/2018/06290/Reference_values_of_neutrophil_lymphocyte_ratio,.21.aspx DOI: https://doi.org/10.1097/MD.0000000000011138

51. Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020;10(6):514-520. https://doi.org/10.1080/20009666.2020.1816276 DOI: https://doi.org/10.1080/20009666.2020.1816276

52. Bergamaschi G, Borrelli de Andreis F, Aronico N, Lenti MV, Barteselli C, Merli S. Internal Medicine Covid-19 Collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239-246. https://doi.org/10.1007/s10238-020-00679-4 DOI: https://doi.org/10.1007/s10238-021-00699-8

53. Lissoni P, Rovelli F, Monzon A, Privitera C, Messina G, Porro G et al. Evidence of Abnormally Low Lymphocyte-To-Monocyte Ratio In Covid-19-Induced Severe Acute Respiratory Syndrome. J Immuno Allerg. 2020;1(2):1-6. http://dx.doi.org/10.37191/Mapsci-2582-6549-1(2)-011 DOI: https://doi.org/10.37191/Mapsci-2582-6549-1(2)-011